Evidence map›Paper›PMID 33950155›Full record

ArticleJAMA2021

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.

Brian J Boyarsky, William A Werbel, Robin K Avery, Aaron A R Tobian, Allan B Massie, Dorry L Segev, Jacqueline M Garonzik-Wang

2 registry-linked trialsAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAMA, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 603 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
603citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05081271 early_phase1terminatednot on this map

COVID-19 Booster Vaccination in Persons With Multiple Sclerosis

TypeinterventionalSponsorGriffin HospitalRan2021 to 2022Enrolled10ConditionsMultiple SclerosisArmsHomologous booster, Heterologous booster
NCT05280158 phase1 / phase2terminatednot on this mapstarted 2022, after this paper: background citation

Phase I/II, Open-Label Dose-Finding Trial of High-Dose mRNA-1273 Booster for Lung Transplant Recipients

TypeinterventionalSponsorUniversity of California, Los AngelesRan2022 to 2023Enrolled19ConditionsLung Transplant Recipient, SARS-CoV-2, ImmunosuppressionArmsmRNA-1273 (Moderna COVID-19 vaccine)
3 · Its place in the literature

Who cites it

603 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023
    Pooled it
  2. Guideline
  3. Pooled it
  4. Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis.Transplant infectious disease : an official journal of the Transplantation Society · 2022
    Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

543 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Brian J BoyarskyDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
William A WerbelDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Robin K AveryDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Aaron A R TobianDepartment of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland.
Allan B MassieDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Dorry L SegevDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Jacqueline M Garonzik-WangDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Funding

Patient Oriented Research in Solid Organ TransplantationK24AI144954 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SEGEV, DORRY L. · 2020 to 2024
$956k
Determinants of chronic kidney disease in African-American live kidney donorsK01DK101677 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MASSIE, ALLAN B · 2015 to 2019
$789k
Aggressive Center Report Cards to Safely Increase Transplantation of Suboptimal KidneysK23DK115908 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI GARONZIK WANG, JACQUELINE M · 2018 to 2021
$516k
Aggressive Organ Procurement Organization Report Cards to Safely Increase Kidney TransplantationF32DK124941 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI BOYARSKY, BRIAN · 2020 to 2020
$81k
NIAID NIH HHS K24 AI144954NIDDK NIH HHS F32 DK124941NIDDK NIH HHS K01 DK101677NIDDK NIH HHS K23 DK115908
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Transplant RecipientsAdolescentAdultAntibodies, ViralCOVID-19COVID-19 VaccinesFemaleHumansImmunization, SecondaryMaleMiddle AgedmRNA VaccinesOrgan TransplantationSARS-CoV-2Spike Glycoprotein, CoronavirusVaccines, SyntheticAntibodies, ViralCOVID-19 VaccinesmRNA VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Vaccines, Synthetic

Identifiers

PMID33950155
PMCPMC8100911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.